APIX Biosciences: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APIX Biosciences
Largest movements
- Current investments -€1.7m
down €1.7m (-100%), from €1.7m to €0
- Intangible fixed assets +€1.5m
up €1.5m (+49.3%), from €3.1m to €4.7m
- Cash +€405,357
up €405,357 (+1,613%), from €25,134 to €430,491
mainly Current investments (+€1.7m) and Debts after one year (+€1.0m)
- Financial fixed assets +€156,027
up €156,027 (+3,121%), from €5,000 to €161,027
- Debts after one year +€1.0m
up €1.0m (+28.6%), from €3.5m to €4.5m
- Profit (loss) carried forward -€620,962
down €620,962 (-298%), from -€208,339 to -€829,300
- Trade debts +€103,562
up €103,562 (+85.3%), from €121,364 to €224,926
- Gross operating margin -€481,410
down €481,410, from €332,260 to -€149,150
- Depreciation +€25,710
up €25,710 (+33.6%), from €76,488 to €102,198
- Taxes +€13,543
up €13,543 (+18.5%), from -€73,046 to -€59,502
- Financial income -€5,986
down €5,986 (-32.0%), from €18,712 to €12,726
- Staff costs -€3,952
down €3,952 (-0.9%), from €431,580 to €427,628
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,413,600 | €5,892,741 | +€479,141 | +8.9% |
| Formation expenses | 20 | €77,133 | €63,147 | -€13,985 | -18.1% |
| Fixed assets | 21/28 | €3,389,400 | €5,132,003 | +€1.7m | +51.4% |
| Intangible fixed assets | 21 | €3,127,990 | €4,668,947 | +€1.5m | +49.3% |
| Tangible fixed assets | 22/27 | €256,410 | €302,029 | +€45,619 | +17.8% |
| Plant, machinery and equipment | 23 | €63,057 | €79,299 | +€16,242 | +25.8% |
| Furniture and vehicles | 24 | €3,208 | €3,985 | +€777 | +24.2% |
| Other tangible fixed assets | 26 | €190,145 | €218,745 | +€28,600 | +15.0% |
| Financial fixed assets | 28 | €5,000 | €161,027 | +€156,027 | +3,121% |
| Current assets | 29/58 | €1,947,067 | €697,591 | -€1.2m | -64.2% |
| Amounts receivable within one year | 40/41 | €211,825 | €262,586 | +€50,760 | +24.0% |
| Trade receivables | 40 | €8,184 | €2,000 | -€6,184 | -75.6% |
| Other amounts receivable | 41 | €203,642 | €260,586 | +€56,944 | +28.0% |
| Current investments | 50/53 | €1,700,000 | €0 | -€1.7m | -100% |
| Cash at bank and in hand | 54/58 | €25,134 | €430,491 | +€405,357 | +1,613% |
| Deferred charges and accrued income | 490/1 | €10,108 | €4,514 | -€5,594 | -55.3% |
| Total equity and liabilities | 10/49 | €5,413,600 | €5,892,741 | +€479,141 | +8.9% |
| Equity | 10/15 | €1,697,591 | €1,076,629 | -€620,962 | -36.6% |
| Contributions | 10/11 | €1,905,930 | €1,905,930 | = | 0.0% |
| Capital | 10 | €1,905,930 | €1,905,930 | = | 0.0% |
| Issued capital | 100 | €1,905,930 | €1,905,930 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€208,339 | -€829,300 | -€620,962 | -298% |
| Amounts payable | 17/49 | €3,716,009 | €4,816,112 | +€1.1m | +29.6% |
| Amounts payable after more than one year | 17 | €3,500,000 | €4,500,000 | +€1.0m | +28.6% |
| Financial debts | 170/4 | €3,500,000 | €4,500,000 | +€1.0m | +28.6% |
| Amounts payable within one year | 42/48 | €188,040 | €294,304 | +€106,264 | +56.5% |
| Trade debts | 44 | €121,364 | €224,926 | +€103,562 | +85.3% |
| Suppliers | 440/4 | €121,364 | €224,926 | +€103,562 | +85.3% |
| Taxes, remuneration and social security | 45 | €66,527 | €69,229 | +€2,702 | +4.1% |
| Taxes | 450/3 | €16,334 | €4,483 | -€11,851 | -72.6% |
| Remuneration and social security | 454/9 | €50,193 | €64,746 | +€14,553 | +29.0% |
| Other amounts payable | 47/48 | €149 | €149 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €27,969 | €21,808 | -€6,161 | -22.0% |
| Remuneration, social security and pensions | 62 | €431,580 | €427,628 | -€3,952 | -0.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €76,488 | €102,198 | +€25,710 | +33.6% |
| Other operating charges | 640/8 | €858 | €1,608 | +€750 | +87.4% |
| Gross operating margin | 9900 | €332,260 | -€149,150 | -€481,410 | |
| Operating profit (loss) | 9901 | -€176,666 | -€680,584 | -€503,918 | -285% |
| Financial income | 75/76B | €18,712 | €12,726 | -€5,986 | -32.0% |
| Recurring financial income | 75 | €18,712 | €12,726 | -€5,986 | -32.0% |
| Financial charges | 65/66B | €10,828 | €12,606 | +€1,778 | +16.4% |
| Recurring financial charges | 65 | €10,828 | €12,606 | +€1,778 | +16.4% |
| Profit (loss) for the period before taxes | 9903 | -€168,782 | -€680,464 | -€511,681 | -303% |
| Income taxes | 67/77 | -€73,046 | -€59,502 | +€13,543 | +18.5% |
| Profit (loss) for the period | 9904 | -€95,737 | -€620,962 | -€525,225 | -549% |
| Profit (loss) for the period to be appropriated | 9905 | -€95,737 | -€620,962 | -€525,225 | -549% |
Source: filed annual accounts (NBB), financial years ended 30 April 2024 and 30 April 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.